0.0021
-0.0188
(-89.95%)
At close: April 16 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Michael A. Martino | CEO, CFO, General Secretary & Director | 550k | -- | 1957 |
| Dr. David Bar-Or M.D. | Founder & Chairman of Scientific Advisory Board | 145.6k | -- | 1949 |
| Ms. April Ramirez | Clinical Trial Manager | -- | -- | -- |
Ampio Pharmaceuticals, Inc.
9800 Mount Pyramid Court
Suite 400
Englewood, CO 80112
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 6
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Corporate Governance
Ampio Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 16, 2025 at 8:00 PM UTC - April 29, 2025 at 8:00 PM UTC
Ampio Pharmaceuticals, Inc. Earnings Date
Recent Events
April 15, 2024 at 12:00 AM UTC
15-12G: Notice of termination of registration of a class of securities under Section 12(g)
April 4, 2024 at 12:00 AM UTC
25: Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
Related Tickers
AKTX Akari Therapeutics, Plc
1.1000
-6.78%
QNNTF Quantum Genomics Société Anonyme
0.1000
0.00%
AXIM AXIM Biotechnologies, Inc.
0.0040
+2.56%
GYX.MU Futura Medical PLC
0.1270
0.00%
ACUT AccuStem Sciences, Inc.
0.6100
+35.28%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
ADXS Ayala Pharmaceuticals, Inc.
0.0317
+3.77%
AMBS Amarantus BioScience Holdings, Inc.
0.0005
0.00%
ANEB Anebulo Pharmaceuticals, Inc.
1.0400
+9.47%
BTTX Better Therapeutics, Inc.
0.0004
+33.33%